1. Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowing. (21st January 2021) Authors: Best, Nicky; Price, Robert G.; Pouliquen, Isabelle J.; Keene, Oliver N. Journal: Pharmaceutical statistics Issue: Volume 20:Number 3(2021) Page Start: 551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020]. (January 2022) Authors: Martin, Neil; Papi, Alberto; Bratton, Daniel J.; Chan, Robert; Howarth, Peter H.; Abbott, Carl B.; Keene, Oliver N.; Bel, Elisabeth H. Journal: Respiratory medicine Issue: Volume 191(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150–300 cells/μL. (May 2019) Authors: Yancey, Steven W.; Bradford, Eric S.; Keene, Oliver N. Journal: Respiratory medicine Issue: Volume 151(2019) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Estimation of a treatment policy estimand for time to event data using data collected post discontinuation of randomised treatment. (7th January 2022) Authors: Hartley, Benjamin; Drury, Thomas; Lettis, Sally; Mayer, Bhabita; Keene, Oliver N.; Abellan, Juan J. Journal: Pharmaceutical statistics Issue: Volume 21:Number 3(2022) Page Start: 612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases. Issue 3 (16th September 2021) Authors: Pavord, Ian D.; Bel, Elisabeth H.; Bourdin, Arnaud; Chan, Robert; Han, Joseph K.; Keene, Oliver N.; Liu, Mark C.; Martin, Neil; Papi, Alberto; Roufosse, Florence; Steinfeld, Jonathan; Wechsler, Michael E.; Yancey, Steven W. Journal: Allergy Issue: Volume 77:Issue 3(2022) Page Start: 778 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Missing data sensitivity analysis for recurrent event data using controlled imputation. (16th June 2014) Authors: Keene, Oliver N.; Roger, James H.; Hartley, Benjamin F.; Kenward, Michael G. Journal: Pharmaceutical statistics Issue: Volume 13:Number 4(2014:Jul./Aug.) Page Start: 258 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction. (29th October 2018) Authors: Keene, Oliver N. Journal: Pharmaceutical statistics Issue: Volume 18:Number 1(2019) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment policy estimands for recurrent event data using data collected after cessation of randomised treatment. (8th November 2018) Authors: Roger, James H.; Bratton, Daniel J.; Mayer, Bhabita; Abellan, Juan J.; Keene, Oliver N. Journal: Pharmaceutical statistics Issue: Volume 18:Number 1(2019) Page Start: 85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗